Catalog No.: PC-35641Not For Human Use, Lab Use Only.
Furmonertinib mesylate (AST-2818, Alflutinib mesylate) is a third generation EGFR mutation selective tyrosine kinase inhibitor, inhibits EGFR active mutations as well as T790M acquired resistant mutation.
Furmonertinib mesylate (AST-2818, Alflutinib mesylate) is a third generation EGFR mutation selective tyrosine kinase inhibitor, inhibits EGFR active mutations as well as T790M acquired resistant mutation.
